Joseph Oliveto insider trades: Milestone Pharmaceuticals (MIST) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Joseph reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 26, 2026 | MIST | ↓ Sell | 167,577 | $2.24 | $375K | Direct | Jan 28, 2026 (2d) |
| Aug 12, 2010 | CHTP | ↑ Buy | 3,500 | $2.87 | $10K | Direct | Aug 16, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MIST insiders
Open-market trades in the last 12 months
About Joseph Oliveto's insider trades
Joseph Oliveto is President and CEO at Milestone Pharmaceuticals (MIST). Since Aug 12, 2010, Joseph has reported 1 open-market purchase worth $10K and 1 sale worth $375K on SEC Form 4. In the last 12 months: 1 sale ($375K).
Their filings also include grants and awards (18 filings), option exercises (3 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MIST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.